Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Magnetic Resonance Imaging

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    1,494 result(s) found for: Magnetic Resonance Imaging. Displaying page 1 of 75.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2011-005917-35 Sponsor Protocol Number: CMC-P014 Start Date*: 2012-03-20
    Sponsor Name:CMC Contrast AB
    Full Title: Accuracy in Diagnosis of Focal Liver Lesions following Oral Administration of CMC-001 Combined with Diffusion Weighted Magnetic Resonance Imaging (MRI) of the Liver. An Open-Label, Non-Randomised, ...
    Medical condition: Focal Liver Lesions in Diagnosed Cancer Patients
    Disease: Version SOC Term Classification Code Term Level
    14.1 10022891 - Investigations 10028049 MRI LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-005249-13 Sponsor Protocol Number: Primovist - OATP1B1 Start Date*: 2007-01-31
    Sponsor Name:Department of Clinical Pharmacology, University of Greifswald
    Full Title: Influence of the OATP1B1 genotype on the hepatic uptake of Primovist® in healthy volunteers and in patients with liver disease
    Medical condition: The trial will be performed in 32 healthy subjects and in 60 patients with a liver disease subjected to MR imaging
    Disease: Version SOC Term Classification Code Term Level
    8.1 10028049 MRI LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-013081-17 Sponsor Protocol Number: BAY 86-6661/91784 (312046) Start Date*: 2009-11-20
    Sponsor Name:Bayer HealthCare Pharmaceuticals, Inc.
    Full Title: Open-label, multi-center, two-stage, age stratified, pharmacokinetic, safety, and efficacy study in children 2 month to < 2 years of age undergoing Magnevist Injection enhanced MRI
    Medical condition: Contrast-enhanced MRI in children 2 month to < 2 years
    Disease: Version SOC Term Classification Code Term Level
    12.0 10028049 MRI LLT
    Population Age: Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2013-000867-10 Sponsor Protocol Number: CD13/10671 Start Date*: 2014-02-13
    Sponsor Name:University of Leeds
    Full Title: Effects of Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction (HF-PEF): Cardiac MRI, Echocardiography, Exercise Physiology & Quality of Life Assessment
    Medical condition: Heart failure with a preserved ejection fraction
    Disease: Version SOC Term Classification Code Term Level
    16.1 10007541 - Cardiac disorders 10069211 Diastolic heart failure LLT
    16.1 100000004848 10028049 MRI LLT
    16.1 10007541 - Cardiac disorders 10052337 Diastolic dysfunction PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2019-001599-12 Sponsor Protocol Number: ASC-Man-P016 Start Date*: 2019-10-21
    Sponsor Name:Ascelia Pharma AB
    Full Title: A Multicenter, Open-label Study to Evaluate the Safety and Diagnostic Efficacy of Mangoral in Patients with Known or Suspected Focal Liver Lesions and Severe Renal Impairment
    Medical condition: MRI in terms of visualization of detected focal liver lesions in patients with known or Suspected focal liver lesions and severe renal impairment
    Disease: Version SOC Term Classification Code Term Level
    22.1 10022891 - Investigations 10028049 MRI LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) SE (Ongoing) PL (Completed) IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-004153-22 Sponsor Protocol Number: 310788 Start Date*: 2007-04-18
    Sponsor Name:Bayer Schering Pharma AG
    Full Title: Open-label multi-center study of magnetic resonance imaging (MRI) with 0.1 mmol/kg BW Gadovist (1.0 M) to assess pharmacokinetics, safety and tolerability in children
    Medical condition: Gadovist as diagnostic imaging agent is approved only for adult patients. Diseases usually representing indications for contrast-enhanced Magnetic Resonance Imaging (CE-MRI) are common also in a pe...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10029815 Nuclear magnetic resonance imaging PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed) SE (Completed) DK (Completed) AT (Completed)
    Trial results: View results
    EudraCT Number: 2021-003825-31 Sponsor Protocol Number: GDX-44-015 Start Date*: 2022-02-28
    Sponsor Name:Guerbet
    Full Title: Gadopiclenol Pharmacokinetics, Safety and Efficacy in Pediatric Patients < 2 Years of Age Undergoing Contrast-enhanced MRI P/0145/2019
    Medical condition: Known or highly suspected abnormalities/ lesion(s) as detected by previous imaging examinations (including the fetal imaging) that need to be investigated by contrast-enhanced MRI of any body regio...
    Disease: Version SOC Term Classification Code Term Level
    22.1 100000004848 10029815 Nuclear magnetic resonance imaging LLT
    22.1 100000004848 10058644 Nuclear magnetic resonance imaging whole body LLT
    Population Age: Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: HU (Ongoing) PL (Ongoing) BG (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2011-005886-19 Sponsor Protocol Number: HGKKRWPHD2 Start Date*: 2012-07-31
    Sponsor Name:Gastroenterology MIDT
    Full Title: Correlation between intestinal blOod flow assessed by magNetic resonance imaging and ulTRASound Techniques (CONTRAST)
    Medical condition: Crohns Disease with active disease
    Disease: Version SOC Term Classification Code Term Level
    14.1 10022891 - Investigations 10059696 Scan with contrast PT
    14.1 10017947 - Gastrointestinal disorders 10011403 Crohn's disease aggravated LLT
    14.1 10022891 - Investigations 10028049 MRI LLT
    14.1 10022891 - Investigations 10045434 Ultrasound scan PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-000690-78 Sponsor Protocol Number: 19773 Start Date*: 2018-10-29
    Sponsor Name:Bayer AG
    Full Title: LowEr Administered Dose with highEr Relaxivity: Gadovist vs Dotarem
    Medical condition: Contrast enhancement in magnetic resonance imaging (MRI) for central nervous system (CNS), magnetic resonance (MR) angiography, liver, kidney and other body regions
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004848 10028049 MRI LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) GB (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2017-003089-29 Sponsor Protocol Number: 69918356615 Start Date*: 2018-04-06
    Sponsor Name:Medical University of Vienna, Department of Biomedical Imaging and Image-guided Therapy
    Full Title: Measuring hallmarks of cancer for non-invasive characterization of breast lesions by simultaneous multiparametric 18F-ethylcholine PET- MRI – an exploratory study
    Medical condition: Patients with imaging suspected breast cancer (BI-RADS 4&5 on conventional imaging, e.g. mammography and ultrasound).
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10006291 Breast neoplasms malignant and unspecified (incl nipple) HLGT
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10006288 Breast neoplasms benign (incl nipple) HLGT
    20.0 10022891 - Investigations 10029815 Nuclear magnetic resonance imaging PT
    20.0 10022891 - Investigations 10036223 Positron emission tomography LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-006724-35 Sponsor Protocol Number: fMRI-CA_2008 Start Date*: 2008-09-08
    Sponsor Name:CMIV
    Full Title: Functional MRI after administration of Gd-based blood pool contrast agents
    Medical condition: This study aims to investigate the possibility to obtain higher functional contrast and better spatial assessment in contrast enhanced functional Magnetic Resonance Imaging (fMRI) as compared to st...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10029820 Nuclear magnetic resonance imaging gadolinium-enhanced LLT
    9.1 10029817 Nuclear magnetic resonance imaging brain LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-022772-31 Sponsor Protocol Number: 20100812v2 Start Date*: 2011-02-09
    Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Psychiatrie und Psychotherapie
    Full Title: Brain Network Dysfunction as a Model for Schizophrenia: Connectivity Alterations using Ketamine and pharmacological Magnetic Resonance Imaging
    Medical condition: Quantify changes of resting-state functional connectivity in response to Esketamine in healthy volunteers.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10029817 Nuclear magnetic resonance imaging brain LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2006-002702-63 Sponsor Protocol Number: 2006RD003 Start Date*: 2007-03-08
    Sponsor Name:South Manchester University Hospital NHS Trust
    Full Title: Does oral Ranitidine improve magnetic resonance cholangio-pancreatogram images allowing clinically useful improvement?
    Medical condition: Image quality improvement in Magnetic Resonance Cholangio-Pancreatogram scans
    Disease: Version SOC Term Classification Code Term Level
    8.1 10058641 Nuclear magnetic resonance imaging abdominal LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2014-002455-26 Sponsor Protocol Number: IRON-CMR Start Date*: 2014-09-20
    Sponsor Name:Karolinska Institute
    Full Title: The use of intravenous Iron oxide as a contrast agent for cardiac magnetic resonance imaging.
    Medical condition: Cardiovascular diseases: Acute myocardial infarction, chronic myocardial infarction, myocardial ischemia, myocarditis, diffuse myocardial fibrosis.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-000952-32 Sponsor Protocol Number: BAY86-4873/16078 Start Date*: 2015-09-24
    Sponsor Name:Bayer HealthCare AG
    Full Title: Open-label, multi-center study to evaluate the safety, efficacy, and plasma gadolinium concentrations after an intravenous injection of 0.1 mL/kg body weight Eovist/Primovist for enhanced magnetic ...
    Medical condition: Magnetic Resonance Imaging
    Disease: Version SOC Term Classification Code Term Level
    18.0 10022891 - Investigations 10072304 Nuclear magnetic resonance imaging liver PT
    Population Age: Newborns, Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2011-005846-36 Sponsor Protocol Number: HGKKRWPHD Start Date*: 2012-07-31
    Sponsor Name:Gastroenterology MIDT
    Full Title: Safe evaluation of obstructive crohns disease using bloodflow Time-intensity curves and Elastography correlated to Neutrocytes and collagen counts and biomechanical properties Obtained in Stenotic ...
    Medical condition: Crohns Disease undergoing elective surgery for intestinal stenosis.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10058829 Elective surgery PT
    14.1 10022891 - Investigations 10059696 Scan with contrast PT
    14.1 10017947 - Gastrointestinal disorders 10011401 Crohn's disease PT
    14.1 10022891 - Investigations 10028049 MRI LLT
    14.1 10022891 - Investigations 10045434 Ultrasound scan PT
    14.1 10017947 - Gastrointestinal disorders 10022699 Intestinal stenosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-011824-79 Sponsor Protocol Number: 91686125 Start Date*: 2009-11-03
    Sponsor Name:Academic Medical Center
    Full Title: Effects of fluoxetine on the outgrowth of the serotonergic system
    Medical condition: We investigate whether the effects fluoxetine (Prozac®) on the outgrowth of the serotonergic system are dependent on age. In a 16 week multicenter randomized, double-blind, placebo controlled trial...
    Disease: Version SOC Term Classification Code Term Level
    15.0 10022891 - Investigations 10056941 MRI brain LLT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-003933-33 Sponsor Protocol Number: 12K3-S-140708 Start Date*: 2006-12-20
    Sponsor Name:Bundeswehr
    Full Title: Clinical value of Choline-Positron-Emission-Tomography combined with Magnetic Resonance Imaging by software fusion for pre-therapeutic staging of prostate cancer
    Medical condition: Clinical value of Choline-Positron-Emission-Tomography combined with Magnetic Resonance Imaging by software fusion for pre-therapeutic staging of prostate cancer referring to histopathological, pos...
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-002880-33 Sponsor Protocol Number: PINDEX Start Date*: 2016-10-28
    Sponsor Name:University of Turku
    Full Title: Bioavailability and pharmacokinetics of intranasal dexmedetomidine in children
    Medical condition: Paediatric patients scheduled for minor procedures such as intra-articular drug injections, hernia repair, bronchoscopy or magnetic resonance imaging.
    Disease:
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2019-001836-69 Sponsor Protocol Number: Vort-MCI_001 Start Date*: 2021-09-17
    Sponsor Name:Medical University of Vienna
    Full Title: Effects of Vortioxetine in Mild Cognitive Impairment measured by Functional Magnetic Resonance Imaging
    Medical condition: Mild cognitive impairment
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 18 21:22:45 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA